LIDYA BAL, M.D.
Family Medicine Physician in STAMFORD, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
LIDYA BAL, M.D. reported a CMS MIPS final score of 79.0781/100 — below the 83.1 national average — and filed 3,122 Medicare Part D claims in 2023.
- 79.0781/100
- MIPS score · -4 vs avg
- 3K
- Part D claims, 2023
- 90%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
LIDYA BAL, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
79 30th percentile higher than 30% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
LIDYA BAL, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about LIDYA BAL, M.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Connecticut
How Family Medicine Physician compares to other specialties among Connecticut providers
Family Medicine Physician share within Connecticut
Family Medicine Physician is one of the more visible NUCC categories in Connecticut
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
LIDYA BAL, M.D.'s 2023 MIPS final score plotted against the Family Medicine Physician national average
- MIPS Final Score
- 79.0781/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Family Medicine Physician) — 79.0781/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Family Medicine Physician US NPIs
79.0781/100 MIPS final score — 4.0 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Family Medicine Physician. Quality dim: 73.195. Cost dim: 57.8987.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
LIDYA BAL, M.D. appears in the CMS NPPES registry as a Family Medicine Physician provider holding M.D. credentials at 32 STRAWBERRY HILL CT FL 4, STAMFORD, CT, 06902, with a listed phone of (203) 276-2566. NPI 1457761512 was issued on 04/29/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BAL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 3,122 prescription claims written by this provider, covering 288 Medicare beneficiaries and totaling roughly $314K in drug spend, split 10% brand-name and 90% generic by claim count, with an opioid prescribing rate of 1.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 79.0781/100 for the 2023 performance year (Quality 73.195, Cost 57.8987), compared with the national average of 83.1.
Family Medicine Physician is a high-volume specialty nationwide, with 147,640 enrolled providers across 56 states and an average of 3,418 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1457761512 |
|---|---|
| Specialty | Family Medicine Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 04/29/2014 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm LIDYA BAL, M.D.'s current license status, disciplinary history, and board certifications with the Connecticut Department of Public Health in Connecticut before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where LIDYA BAL, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
10% brand-name claims vs 90% generic, on 3,122 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 6,834
- Total Day Supply
- 198,872
- Brand vs Generic
- 10% brand / 90% generic
- Brand Drug Cost
- $239K
- Generic Drug Cost
- $71K
- Opioid Claims
- 39 (1.2% rate)
- Antibiotic Claims
- 87
Patient Demographics
- Average Patient Age
- 73.2 years
- Avg HCC Risk Score
- 1.16
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 29, 65-74: 144, 75-84: 83, 85+: 32
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What LIDYA BAL, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
255 claims
- Amlodipine Besylate
Amlodipine Besylate
164 claims
- Levothyroxine Sodium
Levothyroxine Sodium
119 claims
- Metformin Hcl
Metformin Hcl
111 claims
- Gabapentin 99
Gabapentin
99 claims
- Lisinopril 96
Lisinopril
96 claims
- Losartan Potassium 91
Losartan Potassium
91 claims
- Metoprolol Succinate 79
Metoprolol Succinate
79 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 255 |
| Amlodipine Besylate | 164 |
| Levothyroxine Sodium | 119 |
| Metformin Hcl | 111 |
| Gabapentin | 99 |
| Lisinopril | 96 |
| Losartan Potassium | 91 |
| Metoprolol Succinate | 79 |
| Rosuvastatin Calcium | 73 |
| Omeprazole | 72 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Medicine Physician Overview
How LIDYA BAL, M.D. fits within the Family Medicine Physician landscape nationally.
LIDYA BAL, M.D.'s 3,122 claims are below the specialty average of 3,418.
Nearby Family Medicine Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as BAL.
Compare Family Medicine Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Connecticut
Frequently Asked Questions
What is LIDYA BAL, M.D.'s specialty? ▼
How much does LIDYA BAL, M.D. prescribe under Medicare Part D? ▼
What is LIDYA BAL, M.D.'s Medicare quality score? ▼
Where is LIDYA BAL, M.D. located? ▼
What is LIDYA BAL, M.D.'s NPI number? ▼
Does LIDYA BAL, M.D. prescribe more brand-name or generic drugs? ▼
Does LIDYA BAL, M.D. prescribe opioids? ▼
How many Family Medicine Physician providers are there in the US? ▼
What drugs does LIDYA BAL, M.D. prescribe most often? ▼
Does LIDYA BAL, M.D. accept Medicare? ▼
How can I verify LIDYA BAL, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology